Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 10
Submit an article Journal homepage
2,434
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects

Lien De BeckDepartment of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussel, Belgium;Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, BelgiumORCID Iconhttp://orcid.org/0000-0002-8445-0441View further author information
ORCID Icon,
Sarah MelhaouiLaboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, BelgiumView further author information
,
Kim De VeirmanDepartment of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussel, BelgiumView further author information
,
Eline MenuDepartment of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussel, BelgiumView further author information
,
Elke De BruyneDepartment of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussel, BelgiumView further author information
,
Karin VanderkerkenDepartment of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussel, BelgiumView further author information
,
Karine BreckpotLaboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, BelgiumView further author information
&
Ken MaesDepartment of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussel, BelgiumCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-8906-2790View further author information
ORCID Icon show all
Article: e1484981 | Received 27 Apr 2018, Accepted 30 May 2018, Published online: 23 Jul 2018

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Alfonso Serrano Del Valle, Manuel Beltrán-Visiedo, Victoria de Poo-Rodríguez, Nelia Jiménez-Alduán, Gemma Azaceta, Rosana Díez, Beatriz Martínez-Lázaro, Isabel Izquierdo, Luis Palomera, Javier Naval, Alberto Anel & Isabel Marzo. (2022) Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis. OncoImmunology 11:1.
Read now
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now

Articles from other publishers (17)

Zhaoyun Liu, Chun Yang, Xiaohan Liu, Xintong Xu, Xianghong Zhao & Rong Fu. (2023) Therapeutic strategies to enhance immune response induced by multiple myeloma cells. Frontiers in Immunology 14.
Crossref
Zhaoyun Liu, Xintong Xu, Kaining Liu, Jingtian Zhang, Dan Ding & Rong Fu. (2023) Immunogenic Cell Death in Hematological Malignancy Therapy. Advanced Science 10:13.
Crossref
Catharina Muylaert, Lien Ann Van Hemelrijck, Anke Maes, Kim De Veirman, Eline Menu, Karin Vanderkerken & Elke De Bruyne. (2022) Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?. Frontiers in Oncology 12.
Crossref
Megan Johnstone, Delaney Vinaixa, Marcello Turi, Eugenio Morelli, Kenneth Carl Anderson & Annamaria Gulla. (2022) Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma. Cells 11:16, pages 2519.
Crossref
Huju Chi, Yue Hao, Xia Wang, Li Tang, Yongqiang Deng, Xianxiong Chen, Feng Gao, Ou Sha & Guangyi Jin. (2022) A Therapeutic Whole-Tumor-Cell Vaccine Covalently Conjugated with a TLR7 Agonist. Cells 11:13, pages 1986.
Crossref
Christophe Glorieux, Xiaojun Xia & Peng Huang. (2021) The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in Cancer. Cancers 13:17, pages 4426.
Crossref
Annamaria Gulla, Eugenio Morelli, Mehmet K. Samur, Cirino Botta, Teru Hideshima, Giada Bianchi, Mariateresa Fulciniti, Stefano Malvestiti, Rao H. Prabhala, Srikanth Talluri, Kenneth Wen, Yu-Tzu Tai, Paul G. Richardson, Dharminder Chauhan, Tomasz Sewastianik, Ruben D. Carrasco, Nikhil C. Munshi & Kenneth C. Anderson. (2021) Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation. Blood Cancer Discovery 2:5, pages 468-483.
Crossref
Michael Pisano, Yan Cheng, Fumou Sun, Binod Dhakal, Anita D’Souza, Saurabh Chhabra, Jennifer M. Knight, Sridhar Rao, Fenghuang Zhan, Parameswaran Hari & Siegfried Janz. (2021) Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma. Frontiers in Immunology 12.
Crossref
Ken Maes, Anna Mondino, Juan José Lasarte, Xabier Agirre, Karin Vanderkerken, Felipe Prosper & Karine Breckpot. (2021) Epigenetic Modifiers: Anti-Neoplastic Drugs With Immunomodulating Potential. Frontiers in Immunology 12.
Crossref
Sara Ovejero & Jerome Moreaux. (2021) Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma. Exploration of Targeted Anti-tumor Therapy.
Crossref
Kazuya Ishiguro, Hiroshi Kitajima, Takeshi Niinuma, Reo Maruyama, Naotaka Nishiyama, Hitoshi Ohtani, Gota Sudo, Mutsumi Toyota, Hajime Sasaki, Eiichiro Yamamoto, Masahiro Kai, Hiroshi Nakase & Hiromu Suzuki. (2021) Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis. Cell Death Discovery 7:1.
Crossref
Noémie Leblay, Ranjan Maity, Fajer Hasan & Paola Neri. (2020) Deregulation of Adaptive T Cell Immunity in Multiple Myeloma: Insights Into Mechanisms and Therapeutic Opportunities. Frontiers in Oncology 10.
Crossref
Margaret L. Dahn, Brianne M. Cruickshank, Ainsleigh J. Jackson, Cheryl Dean, Ryan W. Holloway, Steven R. Hall, Krysta M. Coyle, Hillary Maillet, David M. Waisman, Kerry B. Goralski, Carman A. Giacomantonio, Ian C.G. Weaver & Paola Marcato. (2020) Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance. Molecular Cancer Therapeutics 19:5, pages 1110-1122.
Crossref
Wenting Zhang, Qinghua Huang, Weiwei Xiao, Yue Zhao, Jiang Pi, Huan Xu, Hongxia Zhao, Junfa Xu, Colin E. Evans & Hua Jin. (2020) Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis. Frontiers in Immunology 11.
Crossref
Alfonso Serrano Del Valle, Alberto Anel, Javier Naval & Isabel Marzo. (2019) Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma. Frontiers in Cell and Developmental Biology 7.
Crossref
Ken Maes & Karine Breckpot. (2019) Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma. Frontiers in Cell and Developmental Biology 7.
Crossref
Rachel E. Cooke, Rachel Koldej & David Ritchie. (2019) Immunotherapeutics in Multiple Myeloma: How Can Translational Mouse Models Help?. Journal of Oncology 2019, pages 1-18.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.